Dergiler / Turkish Journal of Hematology / 2008 / Cilt: 25 - Sayı: 4
Failure of yttrium-90 (90Y)-ibritumomab tiuxetan radioimmunotherapy (Zevalin®) with fatal side effects in relapsed/refractory diffuse large B-cell NHL transformed from other lymphomas
- Sayfa
- 207–208
- DOI
- —